ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 51 filers reported holding ENZO BIOCHEM INC in Q4 2013. The put-call ratio across all filers is 16.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $485,000 | +134.3% | 106,449 | +136.1% | 0.00% | – |
| Q4 2015 | $207,000 | +567.7% | 45,081 | +546.9% | 0.00% | – |
| Q4 2014 | $31,000 | -96.0% | 6,969 | -95.3% | 0.00% | -100.0% |
| Q3 2014 | $770,000 | +12.2% | 149,518 | +4.9% | 0.00% | 0.0% |
| Q2 2014 | $686,000 | +1272.0% | 142,549 | +618.9% | 0.00% | – |
| Q3 2013 | $50,000 | +22.0% | 19,830 | 0.0% | 0.00% | – |
| Q2 2013 | $41,000 | – | 19,830 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBERT FUND ADVISORS, INC. | 5,169,337 | $17,420,000 | 25.49% |
| Roumell Asset Management, LLC | 1,236,309 | $4,166,000 | 9.86% |
| Evermore Global Advisors, LLC | 3,587,251 | $12,089,000 | 2.28% |
| CORRADO ADVISORS, LLC | 198,544 | $669,000 | 0.60% |
| Fondren Management LP | 175,863 | $593,000 | 0.56% |
| MARATHON CAPITAL MANAGEMENT | 247,130 | $832,000 | 0.34% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $322,000 | 0.21% |
| EAM Investors, LLC | 178,939 | $603,000 | 0.15% |
| Leap Investments LP | 11,811 | $40,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 75,900 | $256,000 | 0.03% |